Health TrialsbyHealthPanel

Role of the WHO Labour Care Guide in Improving Maternal and Fetal Outcomes

ConditionLabor and Delivery
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age20-40
SponsorKhyber Teaching Hospital

About this trial

The goal of this randomized controlled trial is to compare the effectiveness of WHO labour care guide (LCG) with the WHO modified partogragh in improving the maternal and fetal outcomes among primigravida and multigravida in active labour .the study evaluates whether use of the Labour care guide leads to improved labour monitoring ,timely clinical decision making and better maternal and neonatal outcomes .this study will answer either of the two questions that is

* There is no difference in maternal and fetal outcomes between women monitored with Wo labour care guide (LCG) and those monitored with the Modified Partogragh * There is a difference in maternal and fetal outcomes between women monitored with the WHO Labour care guide (LCG) and those monitored the modified Partogragh .

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

patient aged 20 to 40 years .

gestational age 37 to 42 weeks as per LMP.

parity UpTo 4

singketon pregnancy on ultrasound

Disqualifiers

patients with breech presenation

pregnant women in whom trial of labor given outside the hospital,

women with complications like gestational diabetes,antepartum hemorrhage,severe preeclampsia/eclampsia and medical disorders complicating the pregnancy

premature rupture of membranes

Trial design

Design model

Parallel

Treatments tested in this trial

  • Group A (Intervention Arm): Monitoring with WHO Labour Care Guide)

    Other intervention

    Group A (Intervention Arm): Monitoring with WHO Labour Care Guide) Women randomized to Group A will be monitored using the World Health Organization Labour Care Guide (LCG) as the intrapartum monitoring tool. The LCG incorporates evidence-based, individualized labour progress thresholds and emphasizes comprehensive maternal and fetal assessment. The following parameters will be recorded at recommended intervals: Cervical dilatation and labour progress Fetal heart rate Uterine contractions Maternal vital signs (pulse, blood pressure, temperature) Assessment of amniotic fluid Supportive care measures (oral intake, mobility, pain relief) Respectful maternity care indicators Clinical reassessment prompts embedded within the LCG will guide decision-making. No traditional alert or action lines will be used; instead, management will be individualized based on dynamic clinical assessment.

  • Group B (Control Arm): Monitoring with Standard WHO Partograph)

    Other intervention

    Women randomized to Group B will be monitored using the standard WHO-modified partograph as the intrapartum monitoring tool. The partograph will include: Cervical dilatation plotted against time Fetal heart rate monitoring Uterine contractions Maternal vital signs Status of membranes and liquor Labour progress will be assessed using the traditional alert and action lines, and clinical decisions (augmentation or operative intervention) will be taken according to institutional protocol based on partographic findings.

Treatment groups

114 Participants
are divided into 2 treatment groups
Group A: Group AExperimental treatment 1 intervention
Group B: Group BActive comparator 1 intervention

Trial outcomes

Primary outcomes

1

Duration of labour

Total duration of labour measured from admission in active labour to delivery (in hours)

Time frame
From admission in active labour until delivery

Secondary outcomes

1

Mode of delivery

Mode of delivery categorized as spontaneous vaginal delivery, operative vaginal delivery, or caesarean section

Time frame
)At the time of delivery
2

Neonatal condition at birth

Assessed by apgar score at 1 and 5 min and need for neonatal resuscitation

Time frame
At birth and within 5 min after delivery
3

Neonatal intensive care unit admission (NICU)

Admission to NICU for any indication

Time frame
Within 24 hours after birth
4

Intrapartum maternal complications

Occurrence of postpartum hemorrhage ,uterine rupture ,fetal distress

Time frame
During labour and immediate portpartum period

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Khyber Teaching Hospital

Lead sponsor

Source ClinicalTrials.gov

This trial is not recruiting at the moment. You can still explore other options: